b. A Classified balance sheet, in report format, at December 31, 2021. Belvidere Pharmaceuticals C-Town Division Trial Balance as of December 31, 2021 A/C Name Trial Balance DR CR Cash 2,000,000 Accounts receivable 4,950,000 Allowance for bad debt 400,000 Other debtors Merchandise Inventory 5,000,000 Store Supplies 2,100,000 Prepaid Insurance 3,200,000 Prepaid rent 3,220,000 Furniture & Equipment 10,000,000 Accumulated deprecation-Fumiture and equipment 3,920,000 Motor Car 4,400,000 Accumulated depreciation-Motor Car 3246,566 Accounts payable 1,500,000 Salary payable Interest payable Uneamed Sales revenue Note Payable, long term Patty Patterson, Capital Withdrawals Sales revenue Sales discount Sales retums and allowances Cost of goods sold Salaries expense Insurance Expense Utilities Expense Rent Expense Depreciation Expense - Furniture and Equipment Depreciation Expense - Motor Car Store Supplies Expense Gain/loss on Disposal of Fixed Asset Bad-Debt Expense Interest Expense 2,000,000 5,800,000 10,500,000 120,000 31,498,934 1,000,000 1,200,000 8,450,500 9,125,000 880,000 3,220,000 58,865,500 58,865,500 5) The Motor Car cost relates to two Vista cars purchased for $2,200,000 each by the company on January 1, 2015. The double-declining balance method of depreciation is used to compute the car's depreciation charges and their expected useful life is 10 years or 100,000 miles. In 2015, 10,000 miles were driven, 16,500 in 2016, 12,600 in 2017, 16,000 in 2018, 16,500 in 2019, 14,800 in 2020 and 16,800 in 2021. The residual value on both car is $241,592 each. On September 1, 2021, the company sold one of the cars to ZM Company for $570,000 on credit. Round off answers to the nearest dollar